These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial. Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549 [TBL] [Abstract][Full Text] [Related]
44. Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography. Donnez J; Schrurs B; Gillerot S; Sandow J; Clerckx F Fertil Steril; 1989 Jun; 51(6):947-50. PubMed ID: 2498131 [TBL] [Abstract][Full Text] [Related]
45. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas]. Nikolov A; Karag'ozov I Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353 [TBL] [Abstract][Full Text] [Related]
47. Review of the endocrine actions of luteinising hormone-releasing hormone analogues in premenopausal women with breast cancer. Nicholson RI; Walker KJ; Walker RF; Read GF; Turkes A; Robertson JF; Blamey RW Horm Res; 1989; 32 Suppl 1():198-201. PubMed ID: 2533149 [TBL] [Abstract][Full Text] [Related]
48. [Intrauterine pregnancy with uterine myoma after downregulation with GnRH analogs]. Naether O; Diedrich K Geburtshilfe Frauenheilkd; 1992 Feb; 52(2):121-2. PubMed ID: 1314757 [TBL] [Abstract][Full Text] [Related]
49. The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypo-oestrogenic by continuous administration of an LHRH agonist. Lumsden MA; West CP; Bramley T; Rumgay L; Baird DT Br J Obstet Gynaecol; 1988 Dec; 95(12):1299-304. PubMed ID: 2975953 [TBL] [Abstract][Full Text] [Related]
50. Treatment of peri-menopausal women: potential long-term therapy with a depot GnRH agonist combined with hormonal replacement therapy. Maheux R; Lemay A Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():13-7. PubMed ID: 1532506 [No Abstract] [Full Text] [Related]
51. Experience with a gonadotrophin-releasing hormone agonist prior to myomectomy--comparison of twice- vs thrice-monthly doses and a control group. Bassaw B; Mohammed N; Jaggat A; Singh-Bhola M; Ramkissoon A; Singh P; Jones K; Maharaj S; Ramsewak S J Obstet Gynaecol; 2014 Jul; 34(5):415-9. PubMed ID: 24678813 [TBL] [Abstract][Full Text] [Related]
52. Uterine leiomyosarcoma diagnosed during treatment with agonist of luteinizing hormone-releasing hormone for presumed uterine fibroid. Loong EP; Wong FW Fertil Steril; 1990 Sep; 54(3):530-1. PubMed ID: 2118862 [TBL] [Abstract][Full Text] [Related]
53. Uterine fibroids: literature review and summary of posters. Benagiano G Horm Res; 1989; 32 Suppl 1():120-4. PubMed ID: 2693322 [TBL] [Abstract][Full Text] [Related]